Myelopathy from Waldenström's macroglobulinemia: improvement after Rituximab therapy. uri icon

Overview

abstract

  • Approximately 20% of patients with Waldenström's macroglobulinemia (WM) have neurological complications; primarily peripheral neuropathies and symptoms related to a hyperviscosity syndrome. We report a rare case of a patient presenting with a slowly progressive myelopathy due to WM who had a marked response to Rituximab therapy.

publication date

  • June 1, 2003

Research

keywords

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Spinal Cord Diseases
  • Waldenstrom Macroglobulinemia

Identity

Scopus Document Identifier

  • 0038378995

Digital Object Identifier (DOI)

  • 10.1023/a:1023912425610

PubMed ID

  • 12825826

Additional Document Info

volume

  • 63

issue

  • 2